ClinicalImpact™ RET-Altered or RET-Driven NSCLC and Thyroid Cancer: Expert Guidance for Improving Outcomes

In this engaging on-demand webcast of a live CCO webinar, learn how experts interpret the latest data on RET inhibitors and how to integrate them into your clinical practice for optimal treatment of patients with RET-altered NSCLC or thyroid cancer.

Marcia Brose, MD, PhD Karen L. Reckamp, MD, MS Laura J. Tafe, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ ABIM MOC: maximum of 1.25 Medical Knowledge MOC point(s) ABPath MOC: maximum of 1.25 Lifelong Learning point(s) Released: April 8, 2021 Expired: No longer available for credit

Watch this on-demand Webcast capturing a live CCO Webinar to learn more about the latest data on RET inhibitors and how to integrate them into your clinical practice for optimal treatment of patients with RET-altered NSCLC or thyroid cancer.

Taofeek K. Owonikoko, MD, PhD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ ABIM MOC: maximum of 0.75 Medical Knowledge MOC point(s) ABPath MOC: maximum of 0.75 Lifelong Learning point(s) Released: February 12, 2021 Expired: No longer available for credit